CME Group: Terrence Duffy proposes $8.34M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CME Group Inc. is the issuer for a proposed sale reported by Terrence Duffy, whose relationship to the issuer is listed as “Self.” The notice lists a proposed sale of 27,000 common shares for an approximate sale date of November 18, 2026, with an aggregate market value of $8,338,917.93. The shares were acquired through an executive compensation grant on March 15, 2025. It also reports a prior sale of 15,000 common shares on September 10, 2026, for gross proceeds of $4,107,222.71.
Key Figures
Key Terms
executive compensation grant financial
aggregate market value financial
gross proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.